| Primary |
| Psoriasis |
51.6% |
| Drug Use For Unknown Indication |
35.1% |
| Pustular Psoriasis |
5.8% |
| Product Used For Unknown Indication |
1.7% |
| Hypertension |
1.2% |
| Psoriatic Arthropathy |
0.7% |
| Prophylaxis |
0.4% |
| Depression |
0.4% |
| Diabetes Mellitus |
0.4% |
| Pain |
0.3% |
| Dermatitis Atopic |
0.3% |
| Acrodermatitis |
0.3% |
| Asthma |
0.3% |
| Blood Cholesterol Increased |
0.3% |
| Dermatitis |
0.3% |
| Headache |
0.2% |
| Hormone Replacement Therapy |
0.2% |
| Anxiety Disorder |
0.2% |
| Hyperlipidaemia |
0.2% |
| Mineral Supplementation |
0.2% |
|
| Psoriasis |
25.3% |
| Death |
8.0% |
| White Blood Cell Count Increased |
7.1% |
| Pyrexia |
5.0% |
| Weight Decreased |
5.0% |
| Influenza Like Illness |
4.5% |
| Pruritus |
4.3% |
| Vomiting |
4.3% |
| Thrombocytopenia |
3.7% |
| Progressive Multifocal Leukoencephalopathy |
3.4% |
| Skin Plaque |
3.4% |
| Headache |
3.2% |
| Guillain-barre Syndrome |
3.0% |
| Psoriatic Arthropathy |
3.0% |
| Rash |
3.0% |
| Platelet Count Decreased |
2.9% |
| Urticaria |
2.9% |
| Migraine |
2.7% |
| Skin Exfoliation |
2.7% |
| Systemic Lupus Erythematosus |
2.7% |
|
| Secondary |
| Psoriasis |
38.8% |
| Pustular Psoriasis |
21.3% |
| Drug Use For Unknown Indication |
17.6% |
| Product Used For Unknown Indication |
9.5% |
| Psoriatic Arthropathy |
3.4% |
| Hypertension |
1.6% |
| Headache |
0.9% |
| Cerebrovascular Accident |
0.9% |
| Asthma |
0.8% |
| Dermatitis |
0.8% |
| Pain |
0.8% |
| Anxiety |
0.6% |
| Arthralgia |
0.6% |
| Breast Cancer |
0.5% |
| Diabetes Mellitus |
0.5% |
| Bipolar Ii Disorder |
0.4% |
| Blood Cholesterol Increased |
0.4% |
| Contraception |
0.3% |
| Depression |
0.3% |
| Gastrooesophageal Reflux Disease |
0.3% |
|
| Death |
22.3% |
| Psoriasis |
12.8% |
| Skin Plaque |
10.6% |
| Pruritus |
7.4% |
| Vomiting |
4.8% |
| Influenza Like Illness |
3.7% |
| Skin Fissures |
3.7% |
| Malaise |
3.2% |
| Non-hodgkin's Lymphoma |
3.2% |
| Skin Exfoliation |
3.2% |
| Bladder Cancer |
2.7% |
| Dermatitis Exfoliative |
2.7% |
| Liver Function Test Abnormal |
2.7% |
| Loss Of Consciousness |
2.7% |
| Pain |
2.7% |
| Rash |
2.7% |
| Skin Lesion |
2.7% |
| Basal Cell Carcinoma |
2.1% |
| Breast Cancer Female |
2.1% |
| Psoriatic Arthropathy |
2.1% |
|
| Concomitant |
| Psoriasis |
43.9% |
| Product Used For Unknown Indication |
13.9% |
| Psoriatic Arthropathy |
13.0% |
| Drug Use For Unknown Indication |
6.8% |
| Hypercholesterolaemia |
4.7% |
| Diabetes Mellitus |
3.1% |
| Depression |
2.6% |
| Anxiety |
2.4% |
| Gout |
2.4% |
| Hypertension |
1.9% |
| Hypothyroidism |
1.2% |
| Vitamin Supplementation |
0.9% |
| Abscess |
0.5% |
| Blood Cholesterol |
0.5% |
| Blood Pressure |
0.5% |
| Cardiac Disorder |
0.5% |
| Contraception |
0.5% |
| Hepatic Neoplasm Malignant |
0.5% |
| Acrodermatitis |
0.2% |
| Anaemia |
0.2% |
|
| Psoriasis |
29.5% |
| Presyncope |
6.6% |
| Glioblastoma |
4.9% |
| Pneumonia |
4.9% |
| Prostate Cancer |
4.9% |
| Upper Respiratory Tract Infection |
4.9% |
| Cheilitis Granulomatosa |
3.3% |
| Drug Ineffective |
3.3% |
| Flatulence |
3.3% |
| Herpes Zoster |
3.3% |
| Hodgkin's Disease Stage Iii |
3.3% |
| Loss Of Consciousness |
3.3% |
| Nasopharyngitis |
3.3% |
| Non-hodgkin's Lymphoma |
3.3% |
| Productive Cough |
3.3% |
| Renal Failure |
3.3% |
| Squamous Cell Carcinoma Of Skin |
3.3% |
| Therapeutic Response Decreased |
3.3% |
| Ventricular Tachycardia |
3.3% |
| Bladder Transitional Cell Carcinoma |
1.6% |
|
| Interacting |
|
| Drug Interaction |
66.7% |
| Staphylococcal Sepsis |
33.3% |
|
